Senior Director, Real-World Value & Evidence — Hematology

6120-Janssen Scientific Affairs, LLC Legal Entity; Horsham (PA); On-site; USD 137,000 - 236,000; Full time

Benefits offered by this job

401(k) plan

Paid time off

Employee benefits

Job summary

Johnson & Johnson in Horsham, PA seeks an Associate Director, Real World Value & Evidence – Hematology to lead RWV&E studies, economic modeling, and dissemination of robust evidence. This role requires strategic thinking, cross-functional collaboration, and a deep understanding of US payer needs in oncology.

The position emphasizes guidance in Integrated Evidence Team plans, publication execution, and alignment with market access strategies to support payer value propositions.

Qualifications

• Master’s degree in health economics and outcomes research, pharmacoepidemiology, health services research, health policy, pharmacy, or related field required.
• Doctorate (PhD) preferred.
• Strong foundation in two or more of: outcomes research, epidemiology, biostatistics, economic modeling.

Responsibilities

• Lead real-world evidence generation and outcomes research for assigned therapeutic areas and marketed products.
• Design, execute, and publish evidence studies and economic models in compliance with standards and SOPs.
• Develop and update research and publication plans to support Integrated Evidence Generation Plan.

Skills

Outcomes Research

Pharmacoeconomics

Biostatistics

Economic Modeling

Healthcare Economics

Project Management

Communication Skills

Cross-Functional Collaboration

Presentation Skills

Education

Master’s degree in health economics and outcomes research or related field

Doctorate (PhD) preferred

Job description

Johnson & Johnson in Horsham, PA seeks an Associate Director, Real World Value & Evidence – Hematology to lead RWV&E studies, economic modeling, and dissemination of robust evidence. This role requires strategic thinking, cross-functional collaboration, and a deep understanding of US payer needs in oncology.

The position emphasizes guidance in Integrated Evidence Team plans, publication execution, and alignment with market access strategies to support payer value propositions.